Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × peginterferon alfa-2b × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Renal Cell 4 Kidney Neoplasms 3 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Skin Neoplasms 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia-Lymphoma, Adult T-Cell 1 HTLV-I Infections 1 Glioma 1 Fallopian Tube Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Brain Neoplasms 1

Interventions

fludarabine phosphate 32 Cyclophosphamide 27 Whole-Body Irradiation 25 Mycophenolic Acid 24 Azacitidine 24 Tacrolimus 20 Peripheral Blood Stem Cell Transplantation 20 Busulfan 20 Cyclosporine 14 Methotrexate 12 Antilymphocyte Serum 12 Decitabine 11 Cytarabine 11 Melphalan 10 Filgrastim 8 fludarabine 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 Clofarabine 6 venetoclax 5 Cyclosporins 5 Sorafenib 4 Injections 4 Flow Cytometry 4 pevonedistat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡